Devdiscourse16h
New IgE Antibody Therapy Shows Promise Against Resistant HER2 Cancers
Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...
CURE4d
First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...
Targeted Oncology4d
HER2DX Test Transforms Treatment Decisions in HER2+ Breast Cancer
A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.
NewsX15h
New Hope For Cancer Patients! Scientists Explore IgE Antibodies As A Game-Changer For HER2 Cancers
Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...
CURE1d
Ongoing Trials Aim to Advance HER2-Negative Breast Cancer Treatment
Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, ...
Targeted Oncology3d
HER2 Therapies Redefine Brain Metastasis Treatment in Breast Cancer
Novel HER2 therapies show strong intracranial efficacy, enabling systemic treatment over local therapy for small, ...
The Print16h
New antibody reduces tumor growth in treatment-resistant breast, ovarian cancers: Study
Immunotherapy, or antibody treatment that activates the patient’s own immune system against cancer, is increasingly being ...
ER+ and PR+ Breast Cancer: Key Statistics and Molecular Insights
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...
Understanding Metastatic Breast Cancer: An In-Depth Look
Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...